MedTrace Logo

Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

NCT03415282 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2018-05-11

No results posted yet for this study

Summary

This is a multicenter, open-label Phase 1b study in pediatric patients age 2-11 years old with extensive atopic dermatitis.

Conditions

Interventions

DRUG

RVT-501 0.5% topical ointment

RVT-501 0.5% topical ointment twice daily (BID) for 4 weeks.

Sponsors & Collaborators

  • Dermavant Sciences GmbH

    lead INDUSTRY

Principal Investigators

  • James Lee, MD, PhD · Dermavant Sciences, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2018-07-24
Completion
2018-08-07
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03415282 on ClinicalTrials.gov